|
|
|
Upsher-Smith Launches AmLactin® XL™
Moisturizing Lotion
Addition to AmLactin® Line: A Clinically Proven Superior
Moisturizer1
MINNEAPOLIS, September 24, 2004—Dry skin
season is fast approaching. This year, there’s a solution to
help alleviate dry skin symptoms: AmLactin® XL™ Moisturizing
Lotion with its unique ULTRAPLEX™ Formulation.
This extension to Upsher-Smith’s AmLactin® product line
features a proprietary lactic acid alpha-hydroxy blend proven
to be a clinically superior moisturizer.1
“Serious dry skin calls for a serious moisturizer,” says an executive
at Upsher-Smith. “Our new AmLactin® XL™ product offers a unique
blend of high potency lactic acids and is clinically
proven to be a superior moisturizer with excellent tolerability.”1
Currently,
Upsher-Smith’s AmLactin® products are among the most recommended
moisturizers for rough, dry skin,
according to a 2003 survey published in Dermatology Times. As an extension
to the successful AmLactin® product line,
AmLactin® XL™’s hydrating properties (including
skin surface hydration and water binding capacity) are proven
significantly more effective in moisturizing skin.1 The AmLactin® family
of moisturizing creams and lotions contains a
special formulation of lactic acid, a naturally occurring alpha-hydroxy acid
and humectant that enables skin to better
retain moisture.
AmLactin® XL™ Moisturizing Lotion ULTRAPLEX™ Formulation
is fragrance free and available without a prescription.
It is designed to moisturize and soften rough, dry skin and is also a great
alternative for diabetic patients suffering from
dry skin. AmLactin® XL™ will be professionally promoted to physicians
and pharmacies beginning September 2004.
For more information and complete product information/patient education, visit
www.upsher-smith.com or call
1.800.654.2299.
Founded in 1919, Upsher-Smith Laboratories,
Inc. is a rapidly growing, fully integrated
pharmaceutical company and a recognized leader in the development of dermatologic
and cardiovascular products. The
company develops, manufactures and markets prescription pharmaceutical, OTC
and cosmetic products and is actively
involved in licensing innovative compounds that are currently in clinical development.
For more information about
Upsher-Smith Laboratories, Inc., call 800.654.2299 or visit www.upsher-smith.com.
Reference:
- Data on file, Upsher-Smith Laboratories, Inc.
|
